These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10894906)

  • 1. Cardiac dysfunction and long-term prognosis in patients with nonobstructive hypertrophic cardiomyopathy and abnormal (123)I-15- (p-Iodophenyl)-3(R,S)-methylpentadecanoic acid myocardial scintigraphy.
    Shimizu M; Ino H; Okeie K; Emoto Y; Yamaguchi M; Yasuda T; Fujino N; Fujii H; Fujita S; Mabuchi T; Nakajima K; Taki J; Mabuchi H
    Cardiology; 2000; 93(1-2):43-9. PubMed ID: 10894906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial scintigraphic study with 123I 15-(p-iodophenyl)-3(R,S)-methylpentadecanoic acid in patients with hypertrophic cardiomyopathy.
    Shimizu M; Yoshio H; Ino H; Taki J; Nakajima K; Bunko H; Takeda R
    Int J Cardiol; 1996 Apr; 54(1):51-9. PubMed ID: 8792185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fatty acid metabolic and perfusion abnormalities in hypertrophied myocardium assessed by dual tracer tomography using thallium-201 and iodine-123-beta-methylpentadecanoic acid].
    Kobayashi H; Nakata T; Han S; Takahashi N; Hashimoto A; Tsuchihashi K; Nagao K; Tanaka S; Shimamoto K; Iimura O
    J Cardiol; 1994; 24(1):35-43. PubMed ID: 8158529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography.
    Nishimura T; Nagata S; Uehara T; Morozumi T; Ishida Y; Nakata T; Iimura O; Kurata C; Wakabayashi Y; Sugihara H; Otsuki K; Wada T; Koga Y
    Ann Nucl Med; 1996 Feb; 10(1):71-8. PubMed ID: 8814730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between reduced myocardial uptake of beta-methyl-p-(123I)- iodophenyl-pentadecanoic acid (123I-BMIPP) and regional diastolic ventricular dysfunction in patients with hypertrophic cardiomyopathy].
    Morozumi T; Ishida Y; Hori M; Kamada T; Yamagami H; Kozuka T; Kusuoka H; Nishimura T
    Kaku Igaku; 1993 Sep; 30(9):1037-47. PubMed ID: 8230824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is I-123-beta-methyl-p-iodophenyl-methylpentadecanoic acid imaging useful to evaluate asymptomatic patients with hypertrophic cardiomyopathy? I-123 BMIPP imaging to evaluate asymptomatic hypertrophic cardiomyopathy.
    Narita M; Kurihara T
    Int J Cardiovasc Imaging; 2003 Dec; 19(6):499-510. PubMed ID: 14690189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of myocardial fatty acid metabolism with left ventricular function and perfusion in cardiomyopathies: by 123I-BMIPP SPECT and 99mTc-tetrofosmin electrocardiographically gated SPECT.
    Zhao C; Shuke N; Okizaki A; Yamamoto W; Sato J; Ishikawa Y; Ohta T; Hasebe N; Kikuchi K; Aburano T
    Ann Nucl Med; 2003 Oct; 17(7):541-8. PubMed ID: 14651352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of BMIPP accumulation at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy.
    Ohtsuki K; Sugihara H; Kuribayashi T; Nakagawa M
    J Nucl Med; 1999 Dec; 40(12):2007-13. PubMed ID: 10616878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of contrast-enhanced MRI with iodine-123 BMIPP for detection of myocardial damage in hypertrophic cardiomyopathy.
    Amano Y; Kumita S; Takayama M; Kumazaki T
    AJR Am J Roentgenol; 2005 Aug; 185(2):312-8. PubMed ID: 16037498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of impaired fatty acid metabolism and dyskinesis in hypertrophic cardiomyopathy with iodine-123-BMIPP.
    Nakata T; Tanaka S; Hamagami S; Miyamoto K; Oh-hori K; Iimura O
    J Nucl Med; 1996 Oct; 37(10):1679-81. PubMed ID: 8862308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is myocardial fatty acid metabolism different between hypertrophic cardiomyopathy and hypertensive hypertrophy?].
    Narita M; Kurihara T; Usami M; Honda M
    Kaku Igaku; 1994 Dec; 31(12):1465-76. PubMed ID: 7861646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between ventricular arrhythmias and myocardial fatty acid metabolism in patients with coronary heart disease: evaluation using iodine-123 beta-methyl-p-iodophenyl-pentadecanoic acid].
    Mori H; Sakamoto T; Ueda Y; Yano K
    J Cardiol; 1999 Aug; 34(2):61-9. PubMed ID: 10466087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy.
    Takeishi Y; Chiba J; Abe S; Tonooka I; Komatani A; Tomoike H
    Eur J Nucl Med; 1992; 19(9):775-82. PubMed ID: 1396872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BMIPP imaging to improve the value of sestamibi scintigraphy for predicting functional outcome in severe chronic ischemic left ventricular dysfunction.
    Hambye AS; Dobbeleir AA; Vervaet AM; Van den Heuvel PA; Franken PR
    J Nucl Med; 1999 Sep; 40(9):1468-76. PubMed ID: 10492367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential application of tissue Doppler imaging to assess regional left ventricular diastolic function in patients with hypertrophic cardiomyopathy: comparison with 123I-beta-methyl iodophenyl pentadecanoic acid myocardial scintigraphy.
    Yamada H; Oki T; Yamamoto T; Tanaka H; Tabata T; Wakatsuki T; Nomura M; Ito S; Thomas JD
    Clin Cardiol; 2004 Jan; 27(1):33-9. PubMed ID: 14743854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial defect detected by 123I-BMIPP scintigraphy and left ventricular dysfunction in patients with idiopathic dilated cardiomyopathy.
    Hashimoto Y; Yamabe H; Yokoyama M
    Ann Nucl Med; 1996 May; 10(2):225-30. PubMed ID: 8800452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of regional wall motion and fatty acid metabolism in coronary artery disease, hypertension, and hypertrophic cardiomyopathy: assessment by dual-isotope SPECT with thallium-201 and iodine-123 beta-methyl fatty acid analogue].
    Hase M; Nakata T; Yonekura S; Tsuchihashi K; Kobayashi H; Nagao K; Tanaka S; Kubota M; Tsuda T; Iimura O
    Kaku Igaku; 1993 May; 30(5):529-39. PubMed ID: 8336412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy.
    Tadamura E; Kudoh T; Hattori N; Inubushi M; Magata Y; Konishi J; Matsumori A; Nohara R; Sasayama S; Yoshibayashi M; Tamaki N
    J Nucl Med; 1998 Mar; 39(3):390-6. PubMed ID: 9529280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial scintigraphy using iodine-123 15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid predicts the response to beta-blocker therapy in patients with dilated cardiomyopathy but does not reflect therapeutic effect.
    Yoshinaga K; Tahara M; Torii H; Akimoto M; Kihara K; Tei C
    J Cardiol; 2000 May; 35(5):343-51. PubMed ID: 10834178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The characteristic feature of myocardial imaging with 123I-labeled 15-(p-iodophenyl)-3R,S-methylpentadecanoic acid in hypertrophic cardiomyopathy with asymmetric septal hypertrophy].
    Ohtsuki K; Sugihara H; Ito K; Matsumoto K; Taniguchi Y; Terada K; Nakagawa T; Shima T; Kuribayashi T; Ochiai M
    Kaku Igaku; 1995 Apr; 32(4):377-85. PubMed ID: 7776544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.